FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2790003237> ?p ?o ?g. }

• W2790003237 endingPage "1069" @default.
• W2790003237 startingPage "1057" @default.
• W2790003237 abstract "This document updates the recommendations on the management of Philadelphia chromosome-negative myeloproliferative neoplasms (Ph-neg MPNs) published in 2011 by the European LeukemiaNet (ELN) consortium. Recommendations were produced by multiple-step formalized procedures of group discussion. A critical appraisal of evidence by using Grades of Recommendation, Assessment, Development and Evaluation (GRADE) methodology was performed in the areas where at least one randomized clinical trial was published. Seven randomized controlled trials provided the evidence base; earlier phase trials also informed recommendation development. Key differences from the 2011 diagnostic recommendations included: lower threshold values for hemoglobin and hematocrit and bone marrow examination for diagnosis of polycythemia vera (PV), according to the revised WHO criteria; the search for complementary clonal markers, such as ASXL1, EZH2, IDH1/IDH2, and SRSF2 for the diagnosis of myelofibrosis (MF) in patients who test negative for JAK2V617, CALR or MPL driver mutations. Regarding key differences of therapy recommendations, both recombinant interferon alpha and the JAK1/JAK2 inhibitor ruxolitinib are recommended as second-line therapies for PV patients who are intolerant or have inadequate response to hydroxyurea. Ruxolitinib is recommended as first-line approach for MF-associated splenomegaly in patients with intermediate-2 or high-risk disease; in case of intermediate-1 disease, ruxolitinib is recommended in highly symptomatic splenomegaly. Allogeneic stem cell transplantation is recommended for transplant-eligible MF patients with high or intermediate-2 risk score. Allogeneic stem cell transplantation is also recommended for transplant-eligible MF patients with intermediate-1 risk score who present with either refractory, transfusion-dependent anemia, blasts in peripheral blood > 2%, adverse cytogenetics, or high-risk mutations. In these situations, the transplant procedure should be performed in a controlled setting." @default.
• W2790003237 created "2018-03-29" @default.
• W2790003237 creator A5001646221 @default.
• W2790003237 creator A5005641797 @default.
• W2790003237 creator A5006360930 @default.
• W2790003237 creator A5006372952 @default.
• W2790003237 creator A5008609620 @default.
• W2790003237 creator A5009381933 @default.
• W2790003237 creator A5012236731 @default.
• W2790003237 creator A5012374853 @default.
• W2790003237 creator A5016216479 @default.
• W2790003237 creator A5018111458 @default.
• W2790003237 creator A5021124944 @default.
• W2790003237 creator A5028356813 @default.
• W2790003237 creator A5039057642 @default.
• W2790003237 creator A5040941721 @default.
• W2790003237 creator A5046772202 @default.
• W2790003237 creator A5046827092 @default.
• W2790003237 creator A5049172299 @default.
• W2790003237 creator A5053726532 @default.
• W2790003237 creator A5059159915 @default.
• W2790003237 creator A5069072959 @default.
• W2790003237 creator A5079400134 @default.
• W2790003237 creator A5085521139 @default.
• W2790003237 creator A5089433535 @default.
• W2790003237 date "2018-02-27" @default.
• W2790003237 modified "2023-10-15" @default.
• W2790003237 title "Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet" @default.
• W2790003237 cites W1247968195 @default.
• W2790003237 cites W1534089060 @default.
• W2790003237 cites W1569941072 @default.
• W2790003237 cites W1653629301 @default.
• W2790003237 cites W1759513527 @default.
• W2790003237 cites W1825604416 @default.
• W2790003237 cites W1972850303 @default.
• W2790003237 cites W1976775588 @default.
• W2790003237 cites W1977174953 @default.
• W2790003237 cites W1979832242 @default.
• W2790003237 cites W1980616014 @default.
• W2790003237 cites W1987790004 @default.
• W2790003237 cites W1990925372 @default.
• W2790003237 cites W1991277248 @default.
• W2790003237 cites W1999664208 @default.
• W2790003237 cites W1999701140 @default.
• W2790003237 cites W2005540959 @default.
• W2790003237 cites W2008799537 @default.
• W2790003237 cites W2009082613 @default.
• W2790003237 cites W2019830589 @default.
• W2790003237 cites W2021443159 @default.
• W2790003237 cites W2024401882 @default.
• W2790003237 cites W2028803880 @default.
• W2790003237 cites W2029548336 @default.
• W2790003237 cites W2029985592 @default.
• W2790003237 cites W2037376001 @default.
• W2790003237 cites W2037516919 @default.
• W2790003237 cites W2049965335 @default.
• W2790003237 cites W2051259791 @default.
• W2790003237 cites W2054255660 @default.
• W2790003237 cites W2058557527 @default.
• W2790003237 cites W2067829130 @default.
• W2790003237 cites W2067978068 @default.
• W2790003237 cites W2069651950 @default.
• W2790003237 cites W2070929302 @default.
• W2790003237 cites W2071990094 @default.
• W2790003237 cites W2072386941 @default.
• W2790003237 cites W2072881492 @default.
• W2790003237 cites W2076578191 @default.
• W2790003237 cites W2083073031 @default.
• W2790003237 cites W2089753725 @default.
• W2790003237 cites W2089993696 @default.
• W2790003237 cites W2090132603 @default.
• W2790003237 cites W2094456737 @default.
• W2790003237 cites W2108052450 @default.
• W2790003237 cites W2113792044 @default.
• W2790003237 cites W2114995805 @default.
• W2790003237 cites W2115351357 @default.
• W2790003237 cites W2116177105 @default.
• W2790003237 cites W2121743767 @default.
• W2790003237 cites W2122395736 @default.
• W2790003237 cites W2127559749 @default.
• W2790003237 cites W2129475142 @default.
• W2790003237 cites W2129629467 @default.
• W2790003237 cites W2133633030 @default.
• W2790003237 cites W2134543618 @default.
• W2790003237 cites W2138709799 @default.
• W2790003237 cites W2143057570 @default.
• W2790003237 cites W2143105159 @default.
• W2790003237 cites W2147370660 @default.
• W2790003237 cites W2157694607 @default.
• W2790003237 cites W2159533809 @default.
• W2790003237 cites W2169561980 @default.
• W2790003237 cites W2177135392 @default.
• W2790003237 cites W2254184051 @default.
• W2790003237 cites W2265314871 @default.
• W2790003237 cites W2292715199 @default.
• W2790003237 cites W2339658711 @default.
• W2790003237 cites W2345645288 @default.
• W2790003237 cites W2374722161 @default.

• next